Azerbaijan vs Congo: New cases tested for RR-/MDR-TB
Azerbaijan
99.0%
in 2024
Congo
99.0%
in 2024
Azerbaijan rank
50th
Congo rank
50th
New cases tested for RR-/MDR-TB over time
- Azerbaijan
- Congo
How they compare
Azerbaijan currently reports 99.0% against 99.0% in Congo, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2013 it was Azerbaijan ahead.
Azerbaijan ranks 50th and Congo ranks 50th of 192 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 87.3% | 8.0% | 79.3% | Azerbaijan |
| 2020s | 97.2% | 77.6% | 19.6% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Azerbaijan or Congo?
- Azerbaijan, at 99.0% against 99.0% in Congo as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Azerbaijan and Congo?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Congo?
- 11 years are reported by both, from 2013 to 2024.
- How do Azerbaijan and Congo rank globally for new cases tested for rr-/mdr-tb?
- Azerbaijan ranks 50th and Congo ranks 50th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.